MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
15.29
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
14.90
-2.55%
After-hours: Aug 15, 2025, 07:55 PM EDT

MiNK Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a -11.71B n/a n/a 11.71B 2.7B 1.56B 1.56B n/a 221.92M n/a n/a n/a
Cost of Revenue
n/a 53.87K 1.88B 45.1K 53.83K 53.57K 5.22B 6.34B 5.85B 37.93K 7.99B 7.7B 7.37B 23.83K 13.38B n/a 16.19K
Gross Profit
n/a n/a -1.88B -45.1K -53.83K -11.71B -5.22B -6.34B 5.85B 2.7B -6.42B -6.14B -7.37B 221.9M -13.38B n/a -16.19K
Operating Income
n/a -2.5M -1.88M -3.07M -3.83M -5.5M -5.22M -6.34M -5.85M -7.89M -7.99M -7.7M -7.37M -6.36M -13.38M -5.61M -3.01M
Interest Income
n/a 39.57K 78.02K 38.36K 16.62K 41.52K 107.29K 146.39K 168.06K 134.84K 92.96K n/a n/a n/a n/a n/a n/a
Pretax Income
-2.77B -2.46M -1.81M -2.7M -3.81M -5.46M -5.12M -6.2M -5.69M -7.77M -6.33M -6.11M -7.78M -5.76M -14.27M -6.34M -3.85M
Net Income
-2.77B -2.46M -1.81M -2.7M -3.81M -5.46M -5.12M -6.2M 162.54M -7.49M -4.58M -4.5M -8.18M -5.76M -14.27M -6.34M -3.85M
Selling & General & Admin
1.27B 808.9K 1.16M 1.06M 1.28M 2.14M 1.8M 1.78M 1.66M 2.08M 1.84M 1.82M 2.1M 2.36M 814.88K 867.9K 594.98K
Research & Development
1.26B 1.41M 540.64K 1.84M 2.55M 3.31M 3.43M 4.56M 4.19M 5.81M 6.15M 5.88M 5.28M 3.95M 3.33M 3.58M 3.1M
Other Expenses
n/a -350.36K 180.94K 169.41K n/a -18 8.00 n/a n/a -15.37K 1.56M 1.56M -401.96K n/a -9.59M n/a n/a
Operating Expenses
2.53B 2.5M 1.88M 3.07M 3.78M 5.45M 5.22M 6.34M 5.85M 7.89M 7.99M 7.7M 7.37M 6.31M 4.15M 4.45M 3.69M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 160.36K n/a 26.38K 848.00 1.55K 881.32K 805.05K 743.7K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -54.04K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 2.5M 1.88M 3.07M 3.83M 5.5M 5.22M 6.34M 5.85M 7.89M 7.99M 7.7M 7.37M 6.31M 4.15M 4.45M 3.69M
Income Tax Expense
n/a n/a n/a n/a n/a -2 n/a n/a -168.22M -279.83K -1.75M -1.61M 402.81K 1.55K n/a n/a n/a
Shares Outstanding (Basic)
3.96M 3.77M 3.74M 3.71M 3.46M 3.46M 3.45M 3.44M 3.4M 3.38M 3.38M 3.36M 3.35M 3.29M 3.29M 2.84M 2.84M
Shares Outstanding (Diluted)
3.96M 3.77M 3.95M 3.71M 3.46M 3.46M 3.45M 3.44M 3.4M 3.38M 3.38M 3.36M 3.35M 3.29M 3.29M 2.84M 2.84M
EPS (Basic)
-7 -0.65 -0.48 -0.73 -1.1 -1.6 -1.5 -1.8 47.90 -2.2 -1.4 -1.3 -2.4 -1.8 -4.3 -2.2 -1.4
EPS (Diluted)
-7 -0.65 -0.46 -0.73 -1.1 -1.6 -1.5 -1.8 47.90 -2.2 -1.4 -1.3 -2.4 -1.8 -4.3 -2.2 -1.4
EBITDA
n/a -2.16M -1.82M -2.86M -3.78M -5.45M -5.17M -6.29M -5.81M -7.85M -7.96M -7.67M -7.35M -5.74M -13.37M -5.59M -3.09M
EBIT
n/a -2.21M -1.88M -2.9M -3.83M -5.5M -5.22M -6.34M -5.85M -7.89M -7.99M -7.7M -7.37M -5.76M -13.38M -5.61M -3.1M
Depreciation & Amortization
n/a 53.87K 62.64K 45.1K 53.83K 53.57K 53.45K 51.91K 45.69K 37.93K 28.43K 28.31K 27.08K 23.83K 20.29K 17.65K 16.19K